Advances in Chronic Kidney is categorized under Periodical Publishers in Philadelphia, PA .
Advances in Chronic Kidney was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania PA 19103 or by phoning (267) 675-0412. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Advances in Chronic Kidney |
| Address: | 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania 19103 |
| Phone Number: | (267) 675-0412 |
| Website Address: | elsevier.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Advances in Chronic Kidney was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact for inquiries that concern Advances in Chronic Kidney by calling the company number (267) 675-0412, as your correspondence is most welcome. Additionally, the physical location of the single location of Advances in Chronic Kidney can be found at the coordinates 39.953751,-75.166673 as well as the street address 1600 John F Kennedy Boulevard # 1800 in Philadelphia, Pennsylvania 19103.
For its online presence, you may visit Advances in Chronic Kidney’s website at elsevier.com and engage with its social media outlets through on Twitter and on Facebook.